Media Summary: Do you use biologically relevant assays to understand compound selectivity? Assessing the selectivity of candidate drugs is ... CETSA® - What, Why and When in One Minute Presentation by Stina Lundgren, PhD, Principal Project Advisor at Pelago Bioscience held at the Virtual CHI Drug Discovery ...
Demo Cetsa - Detailed Analysis & Overview
Do you use biologically relevant assays to understand compound selectivity? Assessing the selectivity of candidate drugs is ... CETSA® - What, Why and When in One Minute Presentation by Stina Lundgren, PhD, Principal Project Advisor at Pelago Bioscience held at the Virtual CHI Drug Discovery ... Are you sure that you know your target? One of the major challenges to phenotypic approaches is the need for target ... Target deconvolution after phenotypic screening can be an extremely challenging task. And we have a solution for that: Characterising cellular target engagement of ERAP1 & 2 using
Launch of CDK2 and CDK4 Alpha SureFire® CETSA® Target Engagement Assay Kit Bridging the Gap Between In Vitro and In Vivo Drug Discovery Translating early-stage drug discovery into clinical success is one ... In this webinar, you will find the details of the study where This video demonstrates the full reproducibility workflow for the CastorNet brain tumor classification study. It covers: Dataset ... Discover a faster, cleaner approach to semiconductor sample preparation with the Tescan FemtoChisel femtosecond laser system ...
